Investors Menu

SEC Filing Details

Document Details

Form
Filing Date
10/21/2013
Document Date
10/21/2013
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Eagle Pharmaceuticals, Inc.
Issuer
EAGLE PHARMACEUTICALS, INC.
Change % Volume Data as of 03/31/2023 11:39 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.